CYP7B1

Chr 8

cytochrome P450 family 7 subfamily B member 1

Also known as: CBAS3, CP7B, SPG5A

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway of extrahepatic tissues, which converts cholesterol to bile acids. This enzyme likely plays a minor role in total bile acid synthesis, but may also be involved in the development of atherosclerosis, neurosteroid metabolism and sex hormone synthesis. Mutations in this gene have been associated with hereditary spastic paraplegia (SPG5 or HSP), an autosomal recessive disorder. [provided by RefSeq, Apr 2016]

GeneReviewsResearchGenerating clinical summary…
MultiplemechanismLOEUF 0.93
Clinical SummaryCYP7B1
🧬
Gene-Disease Validity (ClinGen)
CYP7B1-related disorder of oxysterol accumulation · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
86 unique Pathogenic / Likely Pathogenic· 233 VUS of 617 total submissions
📖
GeneReview available — CYP7B1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.93LOEUF
pLI 0.000
Z-score 1.80
OE 0.57 (0.370.93)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-0.39Z-score
OE missense 1.07 (0.971.18)
272 obs / 254.3 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.57 (0.370.93)
00.351.4
Missense OE?1.07 (0.971.18)
00.61.4
Synonymous OE?1.22
01.21.6
LoF obs/exp: 12 / 20.9Missense obs/exp: 272 / 254.3Syn Z: -1.66

This gene — mechanism propensity

DN
0.6938th %ile
GOF
0.6638th %ile
LOF
0.2483th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

617 submitted variants in ClinVar

Classification Summary

Pathogenic57
Likely Pathogenic29
VUS233
Likely Benign227
Benign20
Conflicting46
57
Pathogenic
29
Likely Pathogenic
233
VUS
227
Likely Benign
20
Benign
46
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
47
6
4
0
57
Likely Pathogenic
17
12
0
0
29
VUS
3
209
17
4
233
Likely Benign
0
2
89
136
227
Benign
0
3
17
0
20
Conflicting
46
Total67232127140612

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

26 pathogenic / likely-pathogenic (of 31) ClinVar copy-number / structural variants overlap CYP7B1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CYP7B1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →